AGP Picks
View all

Daily news on health and wellness in the Falkland Islands

Provided by AGP

Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on April 3, 2026

Space Medicine Market Outlook : Projected to Exceed USD 1,969.7 Million by 2032 with a 11% CAGR|Coherent Market Insights
Retired Regents Professor Dr. Joseph G. Martinez of the UNM College of Education Recently Featured on Close Up Radio
Overcoming Onychomycosis Claims Evaluated: Blue Heron Health News Nail Fungus Treatment Program is On Sale
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Spyre Therapeutics Announces Grants of Inducement Awards
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
VitalRIZE Claims Evaluated: The Max Vitalize Virility Enhancement Support Supplement for Men
Power Life High Impact Plant Protein Claims Evaluated: The Cleanest Vegan Protein Powder on the Market by PowerLife
Weight Watchers Announces Leadership Transition and Board Updates 
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
Maximus Ranked #7 on the Financial Times’ List of The Americas’ Fastest Growing Companies 2026
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

Share us

on your social networks:

Sign up for:

Health Observer Falkland Islands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.